Benchmark raised the firm’s price target on Imax (IMAX) to $44 from $42 and keeps a Buy rating on the shares. Having reset its earnings base higher on record share gains and accelerating international expansion, Imax “exits 2025 as a structurally stronger and more strategically important player within the global theatrical ecosystem,” the analyst tells investors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMAX:
- Imax price target raised to $48 from $47 at JPMorgan
- IMAX Posts Record 2025 Results and Sets Ambitious 2026 Growth Targets
- Imax reports Q4 adjusted EPS 58c, consensus 47c
- IMAX Earnings this Week: How Will it Perform?
- IMAX: Asset-Light Premium Platform Poised for Margin Expansion, Global Growth, and Upside to $42 Target